Home
Editorial
Services
Interview
Q&A
Chronicle Specials
Pharma Mart
ePharmail
Archives
Tenders & Project
Tenders & Enquiries
Pharma Projects
Corporate
Company Profiles
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
Join Pharma
|
Login
Home
>
News
you can get e-magazine links on WhatsApp.
Click here
News
Alcresta Therapeutics announces MGH enrols first patient in clinical trial evaluating use of RELiZORB in pancreatitis patients
April 30, 2025
Strides strengthens anti-inflammatory portfolio with US FDA approval for celecoxib capsules 100 mg, 200 mg, & 400 mg
April 30, 2025
Intuitive and HSSC come together to strengthen India’s healthcare workforce
April 30, 2025
Axtria introduces LUCCID to transform clinical data management with GenAI
April 30, 2025
Signify & SELCO Foundation team-up to solarize 10 24x7 primary health centres in Karnataka under the ‘Swasthya Kiran’ CSR initiative
April 30, 2025
UK MHRA grants marketing approval for BridgeBio Pharma’s Beyonttra to treat ATTR-CM
April 30, 2025
AI will revolutionize industry practices and create new business models: ‘KPMG global tech report: Life sciences insights’
April 30, 2025
ASPA moots forming action group to strengthen presence in MEA
April 30, 2025
Surgery care platform HexaHealth closes $12 million Series A fund raising
April 30, 2025
AbbVie receives US FDA approval for Rinvoq for treatment of adults with giant cell arteritis
April 30, 2025
Boehringer’s new zongertinib data demonstrates durable and clinically meaningful results in patients with HER2 (ERBB2)-mutant advanced NSCLC
April 30, 2025
Spectra Medical introduces EndoliftX, a microfiber based non-surgical aesthetic treatment in India
April 30, 2025
EMA committee recommends approval of AstraZeneca’s fixed-duration Calquence-based regimens for 1st-line chronic lymphocytic leukaemia
April 30, 2025
Bayer begins phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma
April 30, 2025
US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer
April 30, 2025
AstraZeneca to discontinue CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer
April 30, 2025
Merck breaks ground on new $1 billion biologics center of excellence in Wilmington, Delaware
April 30, 2025
Copyright © 2024 Saffron Media Pvt. Ltd |
About us
|
Contact us
|
Advertise
|
Feedback
|
Helpdesk
|
Disclaimer
|
Sitemap
|
Archives
|
Terms & Conditions